Analysis-Can nicotine pouches drive Big Tobacco’s future beyond cigarettes?
Nicotine pouches are a key growth area for Big Tobacco, offering rapid expansion and higher profits, but face regulatory and adoption challenges.Summary
Nicotine pouches, tobacco-free oral products containing nicotine, are becoming a critical growth driver for Big Tobacco companies like Philip Morris International (PMI) and British American Tobacco (BAT). These products, such as PMI’s Zyn and BAT’s Velo, are growing faster than vapes and heated tobacco, attracting investor attention due to higher profit margins and lighter regulation. BAT predicts industry pouch revenue will reach £11 billion ($15 billion) by 2030, overtaking vapes. However, challenges include convincing non-traditional markets to adopt oral nicotine and addressing regulatory concerns over youth uptake. While Sweden and Norway show lower-risk usage patterns, the WHO warns of aggressive marketing and high nicotine strengths. Companies like BAT and PMI emphasize responsible regulation, but stricter rules could slow growth. Investors question whether pouches can replace cigarettes long-term, given their current small market share (2.6% of PMI’s total volumes) and the need for diverse product portfolios to meet varied smoker preferences.
(Source：101 WIXX)
